S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
OTCMKTS:MSLP

MusclePharm - MSLP Stock Forecast, Price & News

$0.0013
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.0013
▼
$0.0013
50-Day Range
N/A
52-Week Range
$0.0002
▼
$0.0002
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$43,407.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MSLP stock logo

About MusclePharm (OTCMKTS:MSLP) Stock

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Stock News Headlines

December 23, 2022 | thestreet.com
Why MusclePharm (MSLP) Stock Is Up Today
July 6, 2022 | finance.yahoo.com
MusclePharm Announces the Launch of FitMiss Energy
February 5, 2023 | Tradewins (Ad)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
June 23, 2022 | seekingalpha.com
MusclePharm Files For Uplisting IPO To Nasdaq
June 7, 2022 | seekingalpha.com
MusclePharm announces additional private placement of $2.5M senior secured notes
May 24, 2022 | finance.yahoo.com
MusclePharm to Present at the LD Micro Invitational XII Conference
May 16, 2022 | benzinga.com
MusclePharm Announces First Quarter 2022...
May 16, 2022 | seekingalpha.com
MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call Transcript
February 5, 2023 | Tradewins (Ad)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
May 16, 2022 | finance.yahoo.com
MusclePharm Announces First Quarter 2022 Financial Results
May 5, 2022 | morningstar.com
Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results
April 14, 2022 | finance.yahoo.com
MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results
April 12, 2022 | finance.yahoo.com
MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022
March 31, 2022 | finance.yahoo.com
MusclePharm Announces Launch into Ready-to-Drink Protein Category
March 11, 2022 | seekingalpha.com
MusclePharm releases preliminary Q421 results
March 11, 2022 | finance.yahoo.com
MusclePharm Announces Preliminary Fourth Quarter and Full Year 2021 Revenue and Begins Fiscal 2022 with Strong First Quarter Guidance
March 2, 2022 | finance.yahoo.com
MusclePharm to Participate at the 34th Annual Roth Conference
February 24, 2022 | finance.yahoo.com
MusclePharm Announces Partnership with Costco for MP Energy Drink in Southern California and Hawaii Regions
February 15, 2022 | seekingalpha.com
MusclePharm teams up with Alliance Sales & Marketing
February 15, 2022 | finance.yahoo.com
MusclePharm Announces National Partnership with Alliance Sales & Marketing for Energy Drink Business
February 7, 2022 | finance.yahoo.com
MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco US
February 2, 2022 | seekingalpha.com
MusclePharm expands distribution channel with Amazon tie-up for energy drink line
February 2, 2022 | finance.yahoo.com
MusclePharm Dramatically Expands Distribution Channel with Amazon.com; Offering Three Flavors of MP Combat Energy Drinks to Its 200 Million Prime Members
November 15, 2021 | finance.yahoo.com
MusclePharm Announces Third Quarter 2021 Financial Results
October 29, 2021 | finance.yahoo.com
MusclePharm adds former Rockstar Energy executive to MP beverage team to lead product development and marketing for two new Performance Energy drinks
October 27, 2021 | finance.yahoo.com
MusclePharm Reports 2014 Fourth-Quarter and Full-Year Financial Results
October 15, 2021 | au.finance.yahoo.com
Global Warming Solutions, Inc. Announces the Appointment of a New Board Member
See More Headlines
Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Company Calendar

Last Earnings
8/10/2015
Today
2/05/2023
Next Earnings (Estimated)
3/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Consumer Staples
Current Symbol
OTCMKTS:MSLP
CUSIP
N/A
CIK
1415684
Web
www.musclepharm.com
Phone
(800) 292-3909
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-12,870,000.00
Net Margins
-38.51%
Pretax Margin
-38.52%
Return on Equity
N/A
Return on Assets
-169.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$50.04 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
33,390,000
Free Float
13,121,000
Market Cap
$43,407.00
Optionable
Not Optionable
Beta
-0.07

Key Executives

  • Mr. Ryan Charles Drexler (Age 51)
    Exec. Chairman & CEO
    Comp: $1.64M
  • John Mills Mills
    Sr. Managing Director
  • Mr. Gary Charles Shirshac (Age 60)
    Interim Chief Financial Officer
  • Mr. Eric Chin (Age 42)
    Chief Accounting Officer & Director
  • Dr. Roscoe M. Moore Jr. (Age 77)
    DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board
  • Mr. Mark E. Groussman (Age 49)
    Consultant

Key Competitors

View All Competitors













MSLP Stock - Frequently Asked Questions

How have MSLP shares performed in 2023?

MusclePharm's stock was trading at $0.0007 at the beginning of 2023. Since then, MSLP shares have increased by 85.7% and is now trading at $0.0013.
View the best growth stocks for 2023 here.

When is MusclePharm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our MSLP earnings forecast.

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) released its earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The business earned $50.48 million during the quarter, compared to analyst estimates of $55 million.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), Avino Silver & Gold Mines (ASM), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).

What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How do I buy shares of MusclePharm?

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.00.

How much money does MusclePharm make?

MusclePharm (OTCMKTS:MSLP) has a market capitalization of $43,407.00 and generates $50.04 million in revenue each year. The company earns $-12,870,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The official website for the company is www.musclepharm.com. The company can be reached via phone at (800) 292-3909 or via email at investors@musclepharm.com.

This page (OTCMKTS:MSLP) was last updated on 2/5/2023 by MarketBeat.com Staff